Otmane El Rhazi from Investor's Business Daily - ETFs RSS.
New York Life plunked down an undisclosed sum to buy IndexIQ last week. Announcing the acquisition, the mega insurer touted the small $1.5 billion ETF provider's expertise in alternative investing. Increasingly, investors expect more for their portfolios than just core holdings with pure beta exposures, said Adam Patti, CEO of IndexIQ, which will be folded into New York Life's MainStay Investments subsidiary after the deal closes in the first half
New York Life plunked down an undisclosed sum to buy IndexIQ last week. Announcing the acquisition, the mega insurer touted the small $1.5 billion ETF provider's expertise in alternative investing. Increasingly, investors expect more for their portfolios than just core holdings with pure beta exposures, said Adam Patti, CEO of IndexIQ, which will be folded into New York Life's MainStay Investments subsidiary after the deal closes in the first half
No comments:
Post a Comment